AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 μg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 μg twice daily for asthma. In a ...
Tags: asthma, drug relationship, use of Symbicort